Assistant Professor, Medicine, Brown University Program in Medicine
Hematology
Dr. Adam J. Olszewski, MD
|
|
Give Review
Adam Olszewski practices Hematology. He researched medicine at Medical University of Warsaw. Adam J. Olszewski is a published MD as well. He has 28 publications published. The latest was: ReCAP: Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute-Designated Cancer Program. He is registered with Medicare and accepts Medicare payments.
Publications
- ReCAP: Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute-Designated Cancer Program.
- Incidence of secondary malignancies among patients with Waldenström macroglobulinemia: An Analysis of the SEER database.
- Survival of patients with neuroendocrine carcinoma of the colon and rectum: a population-based Analysis.
- Treatment selection and outcomes in early-stage classical hodgkin lymphoma: analysis of the national Cancer data base.
- Overall survival and competing risks of death in patients with Waldenström macroglobulinaemia: an Analysis of the Surveillance, Epidemiology and End Results database.
- Low expression of Abelson interactor-1 is linked to acquired drug resistance in Bcr-Abl-induced Leukemia.
- Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphoma.
- Radiation Therapy Administration and Survival in Stage I/II Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue.
- Epidemiology and survival outcomes of ocular and mucosal melanomas: A population-based Analysis.
- Disparate survival and risk of secondary non-Hodgkin lymphoma in histologic subtypes of Hodgkin lymphoma: a population-based study.
- Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: An Analysis of the surveillance, epidemiology and e...
- Severe hypocalcemia after denosumab in a patient with acquired Fanconi Syndrome.
- Comparative outcomes of rituximab-based Systemic therapy and splenectomy in splenic marginal zone lymphoma.
- Population-based prognostic factors for survival in patients with Burkitt lymphoma: An Analysis from the Surveillance, Epidemiology, and End Results database.
- Adjuvant chemotherapy in T1a/bN0 HER2-positive or triple-negative breast Cancers: Application and outcomes.
- Effects of adjuvant chemotherapy in HER2-positive or triple-negative pT1ab breast Cancers: a multi-institutional retrospective study.
- Comparative outcomes of oncologic therapy in gastric extranodal marginal zone (MALT) lymphoma: Analysis of the SEER-Medicare database.
- Remission of primary cutaneous anaplastic large cell lymphoma after a brief course of brentuximab vedotin.
- Survival of patients with marginal zone lymphoma: Analysis of the Surveillance, Epidemiology, and End Results database.
- Survival outcomes with and without splenectomy in splenic marginal zone lymphoma.
- Progressive pericardial effusion during chemotherapy for advanced Hodgkin lymphoma.
- The horizon of antiangiogenic therapy for colorectal Cancer.
- Empowering targeted therapy: lessons from rituximab.
- Thrombotic Thrombocytopenic purpura associated with abacavir in a patient with HIV infection.
- Paroxysmal nocturnal hemoglobinuria presenting with a left intraventricular thrombus in a patient with prior thymoma and aplastic Anemia.
- Chlorambucil-induced Acute interstitial pneumonitis.
- Outcomes of HIV-associated Hodgkin lymphoma in the era of antiretroviral therapy.
Schools
Medical University of Warsaw
Saint Luke39s Roosevelt Hospital
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
St Luke's-Roosevelt Hospital Center -
Medical University of Warsaw
Drug Facts
| NPI NUMBER | 1467436915 | |
| NPPES Provider LastName | OLSZEWSKI | |
| NPPES Provider FirstName | ADAM | |
| NPPES Provider ZIPCode | 028604400 | |
| NPPES Provider State | RI | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 920.0 | |
| Distinct Opioid Count | 6.0 | |
| Opioid Claim Count | 183.0 | |
| Percent Opioid Claims | 19.89 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1467436915 |
| Last Name Of The Provider | OLSZEWSKI |
| First Name Of The Provider | ADAM |
| View All |
Similar Doctors
|
|
Dr. Kathy Theall, MD |
|
|
Dr. Linda R. Hassan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stanley Schwartz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wesam Ahmed, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sabrina M. Witherby, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Iole Ribizzi-Akhtar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anthony G. Thomas, DO
This Doctor is OpenDoctor Recommended.
|